Areteia Therapeutics, Inc.

Biotechnology company · Chapel Hill, North Carolina, United States

Areteia Therapeutics, Inc. is a biotechnology company headquartered in Chapel Hill, North Carolina, United States. Its earliest recorded incorporation is in 2022. It has reported private securities offerings to the US SEC, most recently $360 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Areteia Therapeutics at a glance

Typebiotechnology company

HeadquartersChapel Hill, North Carolina, United States

Earliest incorporation on record2022

SEC CIK1937542

What does Areteia Therapeutics do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $360 million sold (2025).

Frequently asked questions about Areteia Therapeutics

Where is Areteia Therapeutics headquartered?

Areteia Therapeutics, Inc. is headquartered in Chapel Hill, North Carolina, United States.

What does Areteia Therapeutics do?

Areteia Therapeutics, Inc. is a biotechnology company.

When was Areteia Therapeutics founded?

The earliest incorporation on record for Areteia Therapeutics, Inc. is in 2022, according to public company registers.

Similar companies

BioKier, Inc.Chapel Hill, North Carolina, United States
Redbud Labs, Inc.Chapel Hill, North Carolina, United States
Clinical Tools, IncChapel Hill, North Carolina, United States
OncoTrap, Inc.Chapel Hill, North Carolina, United States
Vascular Pharmaceuticals, Inc.Chapel Hill, North Carolina, United States
Falcon Therapeutics, Inc.Chapel Hill, North Carolina, United States
Chaperone Therapeutics, Inc.Chapel Hill, North Carolina, United States
Theravida, Inc.Chapel Hill, North Carolina, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences